These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 24525259)

  • 21. No human risks with pharmaceuticals in water.
    Cooney CM
    Environ Sci Technol; 2005 Oct; 39(19):397A. PubMed ID: 16245799
    [No Abstract]   [Full Text] [Related]  

  • 22. Identification and evaluation of computer models for predicting environmental concentrations of pharmaceuticals and veterinary products in the Nordic environment.
    Wajsman D; Rudén C
    J Expo Sci Environ Epidemiol; 2006 Jan; 16(1):85-97. PubMed ID: 16030525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmaceuticals in the environment: scientific evidence of risks and its regulation.
    Küster A; Adler N
    Philos Trans R Soc Lond B Biol Sci; 2014 Nov; 369(1656):. PubMed ID: 25405974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting the environmental risk assessment of pharmaceuticals: Facts and fantasies.
    Tarazona JV; Escher BI; Giltrow E; Sumpter J; Knacker T
    Integr Environ Assess Manag; 2010 Jul; 6 Suppl():603-13. PubMed ID: 19886731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Introduction to the special issue on environmental risk assessment of pharmaceuticals.
    Knacker T; Metcalfe C
    Integr Environ Assess Manag; 2010 Jul; 6 Suppl():511-3. PubMed ID: 20821716
    [No Abstract]   [Full Text] [Related]  

  • 26. The environmental risk assessment of human pharmaceuticals in the overall EU regulatory affairs process.
    Laenge R; Steger-Hartmann T; Schweinfurth H
    Regul Toxicol Pharmacol; 2006 Aug; 45(3):223-8. PubMed ID: 16716476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Illicit drugs: contaminants in the environment and utility in forensic epidemiology.
    Daughton CG
    Rev Environ Contam Toxicol; 2011; 210():59-110. PubMed ID: 21170703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ranking of pharmaceuticals detected in the environment: aggregation and weighting procedures.
    Voigt K; Brüggemann R
    Comb Chem High Throughput Screen; 2008 Dec; 11(10):770-82. PubMed ID: 19075599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of prioritization approaches to optimize environmental monitoring and testing of pharmaceuticals.
    Burns EE; Carter LJ; Snape J; Thomas-Oates J; Boxall ABA
    J Toxicol Environ Health B Crit Rev; 2018; 21(3):115-141. PubMed ID: 29714645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emerging contaminants in Belgian marine waters: single toxicant and mixture risks of pharmaceuticals.
    Claessens M; Vanhaecke L; Wille K; Janssen CR
    Mar Pollut Bull; 2013 Jun; 71(1-2):41-50. PubMed ID: 23643408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmaceuticals in the environment: expected and unexpected effects on aquatic fauna.
    Fabbri E
    Ann N Y Acad Sci; 2015 Mar; 1340():20-8. PubMed ID: 25557669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Study on environmental risk assessment of drugs: excretion forms to environment].
    Hirata-Koizumi M; Saito M; Miyake S; Hasegawa R
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2006; (124):83-6. PubMed ID: 17405530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessing the exposure risk and impacts of pharmaceuticals in the environment on individuals and ecosystems.
    Arnold KE; Boxall AB; Brown AR; Cuthbert RJ; Gaw S; Hutchinson TH; Jobling S; Madden JC; Metcalfe CD; Naidoo V; Shore RF; Smits JE; Taggart MA; Thompson HM
    Biol Lett; 2013 Aug; 9(4):20130492. PubMed ID: 23804293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulatory demands on data quality for the environmental risk assessment of pharmaceuticals.
    Küster A; Bachmann J; Brandt U; Ebert I; Hickmann S; Klein-Goedicke J; Maack G; Schmitz S; Thumm E; Rechenberg B
    Regul Toxicol Pharmacol; 2009 Dec; 55(3):276-80. PubMed ID: 19607869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medicating the environment: assessing risks of pharmaceuticals to wildlife and ecosystems.
    Arnold KE; Brown AR; Ankley GT; Sumpter JP
    Philos Trans R Soc Lond B Biol Sci; 2014 Nov; 369(1656):. PubMed ID: 25405959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In response: industry perspective.
    Brown AR
    Environ Toxicol Chem; 2014 Sep; 33(9):1915-8. PubMed ID: 25138027
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmaceuticals and the Environment (PiE): Evolution and impact of the published literature revealed by bibliometric analysis.
    Daughton CG
    Sci Total Environ; 2016 Aug; 562():391-426. PubMed ID: 27104492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Assessment of so called organic trace compounds in drinking water from the regulatory, health and aesthetic-quality points of view, with special consideration given to pharmaceuticals].
    Dieter HH; Mückter H
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2007 Mar; 50(3):322-31. PubMed ID: 17334888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening and human health risk assessment of pharmaceuticals and their transformation products in Dutch surface waters and drinking water.
    de Jongh CM; Kooij PJ; de Voogt P; ter Laak TL
    Sci Total Environ; 2012 Jun; 427-428():70-7. PubMed ID: 22551934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmaceuticals in avian scavengers and other birds of prey: A toxicological perspective to improve risk assessments.
    Herrero-Villar M; Taggart MA; Mateo R
    Sci Total Environ; 2024 Oct; 948():174425. PubMed ID: 38969127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.